GlaxoSmithKline Pharmaceuticals Limited board recommends total dividend of Rs. 30 per share

The Board of Directors of GlaxoSmithKline Pharmaceuticals Limited has recommended a total dividend of Rs 30 per share for the financial year ended 31st March, 2021 on Equity Shares of Re.10/- each, subject to the approval of shareholders at the forthcoming Annual General Meeting scheduled on Tuesday, 27th July, 2021, through Video Conferencing / Other Audio Visual Means in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India.

The board has fixed Tuesday, 20th July 2021, as the Record Date for determining entitlement of members to final dividend for the financial year ended 31st March, 2021. If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on and after Tuesday, 27th July 2021 as under:

- To all Beneficial Owners in respect of shares held in dematerialized form as per the data as may be made available by the National Securities Depository Limited and the Central Depository Services (India) Limited as of the close of business hours on Tuesday, 20th July 2021.

- To all Members in respect of shares held in physical form after giving effect to valid transmission or transposition requests lodged with the Company as of the close of business hours on Tuesday, 20th July 2021.

Shares of GLAXOSMITHKLINE PHARMACEUTICALS LTD. was last trading in BSE at Rs.1515.75 as compared to the previous close of Rs. 1530.85. The total number of shares traded during the day was 4218 in over 907 trades.

The stock hit an intraday high of Rs. 1546.5 and intraday low of 1510. The net turnover during the day was Rs. 6435545.

Source : Equity Bulls

Keywords